Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial

Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-24T12:27:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:30:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:23:14.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now appears, replacing the study record content and signaling blocked access to the page.
    Difference
    20%
    Check dated 2026-09-19T18:34:21.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new note indicating 2016 U.S. NIH Grant/Contract funding was added. The page's revision label was updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:03:50.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page revision marker was updated from v3.6.4 to v3.6.5. This indicates a new build of the ClinicalTrials.gov page, typically reflecting minor updates or fixes rather than changes to study data.
    Difference
    0.0%
    Check dated 2026-08-08T18:18:08.000Z thumbnail image

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.